By Scott Meacham We have to make sure that Oklahoma innovators know that there are resources and mentoring available to them here. Twenty-five years ago, Oklahoma did not have a continuum of venture capital serving concept to growth stage companies. Now we do — thanks to assistance from the state acting through OCAST — fromRead more
News
If you are in a decision-making position in an Oklahoma company, is there any reason you wouldn’t want to consider doing business with a startup? You might think that there’s too much risk with a startup. Personally, I like optimism and passion. I favor businesses that stretch, that run lean, and that focus on cashflow. And I like to be part of helping a new business grow. I bet when you think about it, you do too.
Oklahoma City has hit its share of biotech home runs.
Alexion, the biotech giant with a market capitalization of almost $40 billion, grew out of discoveries made at the Oklahoma Medical Research Foundation. Likewise, work at the University of Oklahoma Health Sciences Center gave birth to Novazyme Pharmaceuticals, which Genzyme purchased for more than $200 million in 2001. And Myriad Genetics acquired OMRF spin-off Crescendo Biosciences in 2014 for $270 million.
